627-90-7 | Sigma-Aldrich

Data Sheet - A7011

J. Biol. Chem., 268, 7792-7798 (1993). 10. Heitz, J.R., et al., Arch. Biochem. Biophys., 127, 627-636 (1968). 11. Vallee, B.L., and Hoch, F.L., PNAS, USA, 41, 327- 338 (1955). RC,GY,PHC 01/14

Data Sheet - S1186

Phillips, N. E., and Parker, D. C., J. Immunol., 132, 627-632 (1984). 6. Choquet, D., et al., J. Cell Biol., 121, 355-363 (1993). 7. Tridandapani, S., et al., J. Immunol., 158, 1125- 1132 (

Quick start Guide- EC300

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

GenElute-E Single SpinTissue DNA Kit

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

N27 Rat Dopaminergic Neural Cell Line

medium. 7. Plate cells to T75 flask, culture cells at 5% CO2, 37°C tissue culture incubator. 8. Change medium every day. 9. Cells are ready to be passage upon 70-90%

XP725 Antibody Number-Lot Number 071M4826

.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3 9 10 11 12 33 34 35 36 57 58 59 60 81 82 83 84 1.4 13 14 15 16 37 38 39

Anti-NeuN, clone A60 - Data Sheet

-1171. 3) Nature (1996) 383:624-627. 4) J. Neuroscience (1997) 17:5820-5829. 5) J. Neuroscience (1997) 17:7415-7424. 6) J. Neuroscience (1998) 18:3206-3212. 7) J. Neuroscience (1998) 18:5614-5629

User Manual - EC300

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

GenElute-E Single SpinTissue DNA Kit

of samples 1 6 (+10%) 12 (+10%) Tissue Lysis Buffer 90 µL 594 µL 1,188 µL SmartLyse™ T Protease 5 µL 33 µL 66 µL Final Volume 95 µL 627 µL 1,254 µL 3. Place the

Article: Virus filtration process development optimization

.0 area ratio (lower left graphs, Figure 7 and Figure 8) to the freshness of Feed 3 (hours old rather than days). Feed 2 at pH 6.5 achieved 400-L/m2 with 90% flow decay, whereas Feed 3 at pH 6.5

Material Matters Vol. 1, No. 1

et al. Biosens. Bioelectron. �00�, 17, 53. (6) Brahim, S. et al. Electroanalysis. �00�, 14(9), 627. (7) Rubio Retama, J. et al. Biosens. Bioelectron. �004, 20, 1111. (8) Brahim, S. et al. Microchimica

BioFiles-Issue

Lissamine, Alexa 555 Atto 590 598 634 80 120000 HeNe laser Texas Red, Alexa 594 Atto 594 601 627 85 120000 HeNe laser Texas Red, Alexa 594 Atto 610 605 646 70

Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy

Roth, S.Y., Curr. Opin. Genet. Dev., 11, 155-161 (2001). 16. Kuo, M.H., et al., Genes Dev., 12, 627-639 (1998). 17. Wang, L., et al., Genes Dev., 12, 640-653 (1998). 18. Grant, P.A., et al., Cell

Advanced Applications of Engineered Nanomaterials

regiorandom) ��90�7 (electronic grade) -3.2 eV -5.1 eV PCBM n-type �591�9 -3.7 eV -6.1 eV Prod. No. Fullerene Type Structure ��818� N-methylfulleropyrrolidine (MP-C60) N CH3 �588�7 (1,2

Magna ChIP™ HT96

hm en t Antibody Performance Using Magna ChIP HT96 Panel II 1 84 108 133 212 627 1219 1935 0 500 1000 1500 2000 2500 C on

EZ-Magna ChIP™ HT96 (Cat. No. 17-10078)

hm en t Antibody Performance Using Magna ChIP HT96 Panel II 1 84 108 133 212 627 1219 1935 0 500 1000 1500 2000 2500 C on

Magna ChIP™ HT96 (Cat. No. 17-10077)

hm en t Antibody Performance Using Magna ChIP HT96 Panel II 1 84 108 133 212 627 1219 1935 0 500 1000 1500 2000 2500 C on

An Update on Ligands for Prostanoid Receptors

, 1278-1284 (1999). 69. Chang, C.S., et al., Prostaglandins, 53, 83-90 (1997). 70. Whittle, B.J., et al., Prostaglandins, 19, 605-627 (1980). 71. Skuballa, W., Vorbruggen, H., Adv. Prost. Thromb. Leukot

Panorama Human Protein Functional Array-Signal Transduction

BCL2A1 BCL2-related protein A1 597 BDNF brain-derived neurotrophic factor, transcript variant 5 627 BIRC2 baculoviral IAP repeat-containing 2 329 BIRC3 baculoviral IAP repeat-containing protein

Brochure: LC-MS Contaminants

spectrometry” Bernd O. Keller, Jie Sui, Alex B. Young and Randy M. Whittal Analytica Chimica Acta 627, Issue 1, 3 October 2008, Pages 71-81. However, we have updated the masses listed in the previous

Biowire Fall 2010 - Breakthroughs in Biology

representative MAPs is related to loading volume of plasma samples. >90% of all 10 MAPs can be depleted from 50 µL human plasma. Figure 7. run-to-run depletion consistency of supermix columns Three

XP725 Antibody List Lot 129K4831

5747 PTK2 P NP_001186578.1 y y y 266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y 627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d 556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y 623

XP725 Antibody List Lot 129K4830

5747 PTK2 P NP_001186578.1 y y y 266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y 627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d 556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y 623

XP725 Antibody List Lot 089K4791

5747 PTK2 P NP_001186578.1 y y y 266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y 627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d 556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y 623

XP725 Worksheet for Lot Number 071M4826

2 1 1 GRP75 G4170 626 4 2 1 2 GRP75 G4170 627 4 2 1 3 GRP78 BiP G8918 628 4 2 1 4 GRP78 BiP G8918 629 4 2 1 5 GRP94 G4420 630 4 2 1 6 GRP94 G4420 631 4 2 1

Material Matters Volume 15 number 2 Batteries & Solar Cells

Holt, M. V; Cai, Z.; Bawendi, M. G.; Huang, L.; Buonassisi, T.; Fenning, D. P. Science 2019, 363, 627–631. (18) Saliba, M.; Matsui, T.; Seo, J.-Y.; Domanski, K.; Correa-Baena, J.-P.; Nazeeruddin, M

List of Antibodies

Negative Control NA 623 Rab5 R7904 M y y y 624 Anti Cy3+Cy5 C0992 M NA NA NA 625 Rab 7 R8779 M y y y 626 Rab9 R5404 M y y y 627 RAD1 R5029 P y n/d n/d 628 Rad17 (C-terminal) (C-terminal) R8029 P

Halal Certificate

HEXENOATE 98%, FG W334200 A26302 HC-23SIYV17 626. ETHYL VALERATE 98%, FG W246204 A58632 HC-23SIVH30 627. ETHYL VANILLIN 98%, FCC, FG W246409 A62715 HC-23SINT62 628. ETHYL VINYL KETONE W338210 C29635 HC

Halal Certificate

HEXENOATE 98%, FG W334200 A26302 HC-22SI5438 626. ETHYL VALERATE 98%, FG W246204 A58632 HC-22SIXY51 627. ETHYL VANILLIN 98%, FCC, FG W246409 A62715 HC-22SIVH83 628. ETHYL VINYL KETONE W338210 C29635 HC

XP725 Antibody List

Cy3+Cy5 625 Rab 7 R8779 29448, 19349, 7879 Rab7,RAB7 NP_076440.1,NP_033031.2,NP_004628.4 M y y y 626 Rab9 R5404 84589, 9367, 56382 RAB9,Rab9 NP_445910.1,NP_004242.1,NP_062747.1 M y y y 627 RAD1 R5029 5810